Fisher Asset Management
ANIP icon

Fisher Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Fisher Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56
Closed -$3.25K – 985
2023
Q3 		$3.25K Hold
56
– – ﹤0.01% 1128
2023
Q2 		$3.01K Hold
56
– – ﹤0.01% 1128
2023
Q1 		$2.22K Buy
+56
New +$2.36K ﹤0.01% 1100

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management's ANIP Position: Q4 2023 in Review

Fisher Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2023, closing a stake of 56 shares — an estimated $3.25K sold.

Fisher Asset Management first reported a position in ANIP in Q1 2023 and held it in 3 quarters. The position peaked at $3.25K in Q3 2023. 181 funds tracked by Wall St. Rank hold ANIP as of Q4 2023.

  • Fisher Asset Management reported no remaining ANI Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Fisher Asset Management sold 56 ANI Pharmaceuticals shares in Q4 2023, an estimated $3.25K.
  • Fisher Asset Management first reported a position in ANI Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Fisher Asset Management's ANI Pharmaceuticals position peaked at $3.25K in Q3 2023.
  • 181 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.